Channick, R., Delcroix, M., Galiè, N., Ghofrani, H. A., Jansa, P., Brun, F.-O., … Simonneau, G. (2013). Do parameters of cardiac function predict long-term outcomes in patients with pulmonary arterial hypertension? Data from SERAPHIN, a randomized controlled study of macitentan. Chest, 144(4), 870B-870B. https://doi.org/10.1378/chest.1701644

Channick, Richard, Marion Delcroix, Nazzareno Galiè, Hossein A. Ghofrani, Pavel Jansa, Franck-Olivier Le Brun, Sanjay Mehta, et al. “Do parameters of cardiac function predict long-term outcomes in patients with pulmonary arterial hypertension? Data from SERAPHIN, a randomized controlled study of macitentan.” Chest 144, no. 4 (October 2013): 870B-870B. https://doi.org/10.1378/chest.1701644.

Channick R, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Brun F-OL, et al. Do parameters of cardiac function predict long-term outcomes in patients with pulmonary arterial hypertension? Data from SERAPHIN, a randomized controlled study of macitentan. Chest. 2013 Oct;144(4):870B-870B.

Channick, Richard, et al. “Do parameters of cardiac function predict long-term outcomes in patients with pulmonary arterial hypertension? Data from SERAPHIN, a randomized controlled study of macitentan.” Chest, vol. 144, no. 4, Elsevier BV, Oct. 2013, pp. 870B-870B. Crossref, doi:10.1378/chest.1701644.

Channick R, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Brun F-OL, Mehta S, Perchenet L, Pulido T, Sastry BK, Sitbon O, Souza R, Torbicki A, Rubin LJ, Simonneau G. Do parameters of cardiac function predict long-term outcomes in patients with pulmonary arterial hypertension? Data from SERAPHIN, a randomized controlled study of macitentan. Chest. Elsevier BV; 2013 Oct;144(4):870B-870B.